FIELD: medicine. SUBSTANCE: invention refers to medicine, namely physiotherapy, and can be used for treating patients with gallbladder hypomotor dysfunction ...

... the liver and gallbladder, depression of liver-QI. Ultrasonic display: liver ... does not increase, Strengthen the reliability of cholesterol polyps diagnosis.

... damage to bones or liver has occurred or with gallstones. Low values are probably not significant but can rarely be associated with hypophosphatasia. GGT is ...

Having a history of liver damage. In-vitro fertilization (IVF) treatment ... of having intrahepatic cholestasis, including but not limited to intrahepatic ...

In some embodiments, a promoter is a liver-specific promoter, for example a TBG promoter. [0009]. In some embodiments, a miR-375 molecule comprises the sequence ...

... the toxins are excreted through the kidneys before they can cause liver damage. ... does not exhibit the adverse side effects caused by the ingestion of ...

... no evidence of GVHD or lymphoma in either colon or liver. In TCD BM ... The remaining 60% of the hosts did not develop lymphoma cells in blood, and ...

In a preferred embodiment, the humanized antibody is not an agonist of the c-Kit receptor and does not activate mast cells which could lead to anaphylactoid ...

... not necessarily provided answers to every specific question of clinical ... having recurrent CHD events in persons with established CHD. † Risk factors ...

inflammation Immune Conditions * fights infection Liver Conditions * aids the function of the liver and gallbladder * ... of everyday life usually does not ...

But still, removal of the gallbladder does not eliminate the ... The use of the drug does not affect the ability to carry out potentially ...

Examples of Notch decoy proteins can be found in U.S. Patent No. 7,662,919 B2, issued February 16, 2010, U.S. Patent Application Publication No. US 2010-0273990 ...

Recently it has been found that FXR can regulate the regeneration of the liver ... Figure 14 shows that the treatment with ivermectin does not affect the food ...

Ideally, approaches for the treatment of liver cirrhosis should ... A) Sub-threshold levels of HGF, Dihexa or Nle1-AngIV do not affect basal spine numbers.

... liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics ... The heptapeptides of the invention having the formulae MPA-Tyr-D ...

... the liver expressing the DiD above the background levels 24 hpi, D: GFP ... Such lipids include but are not limited to lipids having sulfur atoms in ...

Liver cleansing in the form of tubage can be carried out not only at the ... Helichrysum helps well with pathologies of the gallbladder and liver. Its ...

... not having pediatric cholestasis or pediatric cholestatic liver disease. ... In various embodiments, the administration of the ASBTI does not result in a ...

Gallbladder disease · Sludge · Hypealimentation · Pseudiskudge ; conditions that slow or obstruct the flow of bile · echogenic bile, calcium bilirubinate, ...

the work of bending over can not be adhered to.Often be forced to straighten ... Return liver, gallbladder, lung meridian.Function heat-clearing and ...